German dermatologists are reporting a surge in hair loss cases linked to a viral TikTok trend called “Heftiger Zug” (German for “strong pull”), where users aggressively tug their hair to stimulate growth—a practice now classified as a form of trichotillomania by the DSM-5. Published this week in the Journal of the German Society of Dermatology, the study documents 147 cases in Berlin and Munich clinics since January 2026, with 68% of patients under 25 and 72% female. The trend, amplified by YouTube influencers, has led to irreversible follicle damage in 12% of cases, according to lead researcher Dr. Klaus Weber of Charité Universitätsmedizin.
Why Is This Trend Causing Permanent Hair Loss—and Who’s Most at Risk?
The “Heftiger Zug” method exploits the anagen effluvium mechanism—where pulling hair in its growth phase (anagen) triggers a misguided inflammatory response in the dermal papilla, the hair follicle’s nutrient-supplying core. Unlike alopecia areata, which targets immune-mediated follicle destruction, this trend directly traumatizes the bulb matrix cells, halting keratin production. “We’re seeing minoxidil [a topical vasodilator] fail in 40% of cases because the follicle’s stem cell niche is physically disrupted,” Weber told Archyde.
In Plain English: The Clinical Takeaway
- It’s not “stimulating” growth—it’s damaging it. Pulling hair aggressively confuses the follicle’s repair cycle, leading to fibrosis (scarring) in 12% of cases.
- Young women are the hardest hit. 72% of cases involve females aged 18–24, likely due to social media normalization of “hair hack” trends.
- No topical treatment reverses scarring. Platelet-rich plasma (PRP) therapy shows limited efficacy for early-stage cases, but once fibrosis sets in, hair regrowth is permanent.
How the Trend Spread—and Why Regulators Are Scrambling to Respond
The phenomenon originated in German-speaking YouTube communities in late 2025, where influencers claimed the technique mimicked manual scalp massage used in East Asian hair restoration. However, German dermatologists note critical differences: legitimate massage targets the scalp’s superficial fascia without follicle trauma, whereas “Heftiger Zug” involves direct bulb avulsion, a known trigger for telogen effluvium (premature shedding).
The German Federal Institute for Risk Assessment (BfR) issued a public advisory this week, classifying the practice as a cosmetic hazard under EU Regulation 1223/2009. “This is not a cultural practice—it’s a public health risk,” said BfR Director Dr. Anja Karliczek. Meanwhile, the European Medicines Agency (EMA) has flagged the trend for potential off-label minoxidil misuse, as some users combine pulling with topical treatments, increasing irritation.
| Demographic | % of Cases | Primary Symptom | Reversibility |
|---|---|---|---|
| Females 18–24 | 72% | Patchy anagen effluvium | Partial (with PRP) |
| Males 25–35 | 28% | Follicular fibrosis | Permanent |
| Transgender patients (MTF) | 10% | Combined telogen + anagen | Variable |
“We’re seeing a generation of patients who believe ‘pain equals progress.’ The data shows that 89% of those who tried ‘Heftiger Zug’ did so after watching a single influencer video—there’s no gatekeeping.” —Dr. Weber, Charité Universitätsmedizin
Funding, Bias, and the Role of Social Media in Medical Misinformation
The study was funded by the German Research Foundation (DFG) and conducted independently of pharmaceutical interests. However, critics note the trend’s rapid spread correlates with algorithm amplification of “hair growth hacks” on platforms like YouTube, where ads for low-dose finasteride (a DHT blocker) and topical ketoconazole (an antifungal repurposed for DHT inhibition) appear alongside “Heftiger Zug” tutorials. A 2023 Nature study found that 63% of viral hair-loss content on TikTok contained no clinical evidence.
YouTube’s Community Guidelines Enforcement Team has removed 1,200+ videos since February 2026 under its “Medical Misinformation Policy”, but dermatologists warn the damage is already done. “By the time we see patients, they’ve already caused irreversible harm,” said Dr. Weber.
Contraindications & When to Consult a Doctor
Individuals with the following conditions should avoid any form of aggressive hair pulling or manipulation:
- Active scalp psoriasis or eczema: Trauma exacerbates inflammation, worsening koebnerization (lesion formation at injury sites).
- History of trichotillomania: The trend exploits compulsive behaviors, risking exacerbation of OCD-related pulling.
- Thyroid disorders (hypo/hyperthyroidism): Baseline hair shedding is already elevated; mechanical stress accelerates telogen effluvium.
- Postpartum or chemotherapy-induced alopecia: Follicles are in a vulnerable anagen phase and cannot withstand additional trauma.
Seek immediate medical attention if you experience:
- Sudden patchy bald spots (suggesting anagen effluvium).
- Scalp tenderness or pus-filled bumps (signs of folliculitis or bacterial superinfection).
- Hair that breaks easily (indicating trichorrhexis nodosa, a structural weakness).
What Happens Next: Regulatory Crackdowns and Long-Term Risks
The EMA is reviewing whether to classify “Heftiger Zug” as a cosmetic device hazard, potentially requiring YouTube to add disclaimers to related content. In the U.S., the FDA has not yet acted but is monitoring reports of off-label minoxidil misuse tied to the trend. Longitudinal data from Charité’s follow-up cohort suggests that even “mild” cases of anagen effluvium take 18–24 months to resolve, with 35% of patients reporting persistent thinning.
For those already affected, dermatologists recommend:
- Low-level laser therapy (LLLT): Shown in a JAMA Dermatology 2018 study to stimulate dormant follicles with 90% efficacy in early-stage cases.
- Oral finasteride (for males only): Reduces DHT-related follicle miniaturization but does not reverse fibrosis.
- Psychological support: CBT for trichotillomania has a 60% success rate in reducing compulsive pulling (Journal of Obsessive-Compulsive and Related Disorders, 2017).
References
- Journal of the German Society of Dermatology (2026). “Anagen Effluvium Secondary to Viral ‘Heftiger Zug’ Trend: A Multicenter Analysis.” DOI: 10.1007/s00105-026-05345-7
- German Federal Institute for Risk Assessment (BfR). “Advisory on Cosmetic Hair Trauma Trends.” June 7, 2026.
- Nature (2023). “The Spread of Medical Misinformation on Social Media Platforms.” DOI: 10.1038/s41598-023-39000-1
- JAMA Dermatology (2018). “Low-Level Laser Therapy for Androgenetic Alopecia.” PMID: 30556531
- Journal of Obsessive-Compulsive and Related Disorders (2017). “Cognitive Behavioral Therapy for Trichotillomania.” PMID: 29155490
